These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29240863)

  • 1. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA; Ilie C
    J Drugs Dermatol; 2017 Dec; 16(12):1269-1273. PubMed ID: 29240863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
    Jellinek NJ; Korotzer A
    J Drugs Dermatol; 2015 Aug; 14(8):871-5. PubMed ID: 26267732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies.
    Gupta AK; Hall S; Zane LT; Lipner SR; Rich P
    J Dermatolog Treat; 2018 Feb; 29(1):44-48. PubMed ID: 28521541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC; Joseph WS
    J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
    Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R
    J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis.
    Gupta AK; Cooper EA
    Skin Therapy Lett; 2021 Jan; 26(1):5-10. PubMed ID: 33539062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical and device-based treatments for fungal infections of the toenails.
    Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
    Toledo-Bahena ME; Bucko A; Ocampo-Candiani J; Herz-Ruelas ME; Jones TM; Jarratt MT; Pollak RA; Zane LT
    J Drugs Dermatol; 2014 Sep; 13(9):1124-32. PubMed ID: 25226015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tavaborole in Difficult-to-Treat Onychomycosis Cases: A Post-hoc Assessment of Phase III Subjects.
    Aly R; Gupta AK; Winter T; Zane LT; Vlahovic T
    J Drugs Dermatol; 2017 Oct; 16(10):1016-1021. PubMed ID: 29036255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial designs for topical antifungal treatments of onychomycosis and implications on clinical practice.
    Rich P; Vlahovic TC; Joseph WS; Zane LT; Hall SB; Gellings Lowe N; Adigun CG
    Cutis; 2017 Oct; 100(4):259-264. PubMed ID: 29136060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label Study.
    Rich P; Spellman M; Purohit V; Zang C; Crook TJ
    J Drugs Dermatol; 2019 Feb; 18(2):190-195. PubMed ID: 30811142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Eichenfield LF; Elewski B; Sugarman JL; Rosen T; Vlahovic TC; Gupta AK; Stein Gold L; Pillai R; Guenin E
    J Drugs Dermatol; 2020 Sep; 19(9):867-872. PubMed ID: 33026753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson B; Caldwell B
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.
    Vlahovic TC; Coronado D; Chanda S; Merchant T; Zane LT
    J Drugs Dermatol; 2016 Jan; 15(1):89-94. PubMed ID: 26741386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tavaborole 5% Solution: A Novel Topical Treatment for Toenail Onychomycosis.
    Gupta G; Foley KA; Gupta AK
    Skin Therapy Lett; 2015 Nov; 20(6):6-9. PubMed ID: 27224843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tavaborole - a treatment for onychomycosis of the toenails.
    Gupta AK; Versteeg SG
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.